MRAS Antikörper (AA 105-208) (HRP)
Kurzübersicht für MRAS Antikörper (AA 105-208) (HRP) (ABIN735827)
Target
Alle MRAS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 105-208
-
Kreuzreaktivität
- Ratte
-
Homologie
- Human,Mouse,Cow,Horse,Chicken
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human MRAS
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handhabung
- Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- MRAS (Muscle RAS Oncogene Homolog (MRAS))
-
Andere Bezeichnung
- M-RAS/Mras
-
Hintergrund
-
Synonyms: muscle RAS oncogene homolog precursor, M ras, Muscle and microspikes Ras, Muscle Ras oncogene homologue, R ras3, R-ras3, Ras related protein MRas, Ras related protein RRas3, RRas3, XRas.
Background: MRas is a member of the RAS superfamily of GTP-binding proteins which are membrane-anchored, intracellular signal transducers responsible for a variety of normal cellular functions. They are oncogenically activated in a significant fraction of tumors. MRas participates in reorganisation of actin cytoskeleton. It is also involved in focal adhesion and can activate MAPK signalling.
-
Gen-ID
- 22808
Target
-